Envestnet Portfolio Solutions Inc. reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 2.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,237 shares of the company’s stock after selling 1,647 shares during the period. Envestnet Portfolio Solutions Inc. owned about 0.05% of Henry Schein worth $4,653,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Nuance Investments LLC boosted its position in shares of Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after buying an additional 414,748 shares during the period. Olstein Capital Management L.P. boosted its position in shares of Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after buying an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of Henry Schein during the third quarter worth about $515,000. Private Management Group Inc. boosted its position in shares of Henry Schein by 5.7% during the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after buying an additional 18,882 shares during the period. Finally, Equitable Trust Co. acquired a new position in shares of Henry Schein during the fourth quarter worth about $417,000. 96.62% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on HSIC shares. Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Mizuho assumed coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and upped their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Finally, Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and an average target price of $81.10.
Henry Schein Price Performance
NASDAQ:HSIC opened at $72.00 on Wednesday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock’s 50 day moving average price is $74.85 and its two-hundred day moving average price is $72.63. The firm has a market capitalization of $8.94 billion, a price-to-earnings ratio of 29.63, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.49.
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 EPS. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Consumer Staples Stocks, Explained
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Growth Stocks: What They Are, What They Are Not
- 3 Must-Own Stocks to Build Wealth This Decade
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.